Plasma homocysteine and lipoprotein (a) levels as risk factors for atherosclerotic vascular disease in epileptic children taking anticonvulsants

Tumer L., Serdaroglu A., Hasanoglu A., Biberoglu G., Aksoy E.

ACTA PAEDIATRICA, vol.91, no.9, pp.923-926, 2002 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 91 Issue: 9
  • Publication Date: 2002
  • Doi Number: 10.1080/080352502760272597
  • Journal Name: ACTA PAEDIATRICA
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.923-926


Aim: To assess the effect of anticonvulsant treatment on plasma homocysteine level and lipoprotein (a) in epileptic children. Methods: Plasma total homocysteine, folate, vitamin B-12 and lipoprotein (a) concentrations were measured in 111 epileptic children taking anticonvulsant drugs for longer than 12 mo. Forty-six healthy, sex- and age-matched children served as controls. Results: Patients and controls differed significantly in concentrations of homocysteine (p < 0.05) and lipoprotein (a) (p < 0.001). The number of patients with homocysteine concentrations of >9 muM was significantly higher in the patient group than in the control group. A significant inverse relationship was found between vitamin B-12 folate levels and plasma homocysteine levels in the patient group; 28.8% of the patient group had lipoprotein (a) concentrations above the cutoff value (30 mg/dl) for increased risk of early atherosclerosis, whereas none of the control patients had concentrations above this value.